SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Cancer facts and figures 2006. Atlanta: American Cancer Society; 2006. Available from http://www.cancer.org.
  • 2
    Shavers VL,Brown ML,Potosky AL, et al. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer. J Gen Intern Med. 2004; 19: 146155.
  • 3
    Lubeck DP,Kim H,Grossfeld G, et al. Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol. 2001; 166: 22812285. Comment in: J Urol. 2001; 166: 2291–2292.
  • 4
    Schapira MM,Mcauliffe TL,Nattinger BA. Treatment of localized prostate cancer in African-American compared with Caucasian men. Medical Care. 1995; 33: 10791088.
  • 5
    Harlan L,Brawley O,Pommerenke F,Wali P,Kramer B. Geographic, age, and racial variation in the treatment of Local/Regional Carcinoma of the prostate. J Clin Oncol. 1995; 13: 93100. Comment in: J Clin Oncol. 1995; 13: 1823.
  • 6
    Freedland SJ,Isaacs WB. Explaining racial differences in prostate cancer in the United States: sociology or biology? Prostate. 2005; 62: 243252.
  • 7
    Young CD,Roach MIII. Race and prostate cancer: what do we know? Prostate J. 2000; 2: 3341.
  • 8
    Underwood W,De Monner S,Ubel P,Fagerlin A,Sanda MG,Wei JT. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol. 2004; 171: 15041507. Comment in: J Urol. 2004; 172(4 pt 1): 1547–1548; author reply 1548.
  • 9
    Ko YJ,Bubley GJ. Prostate cancer in the older man. Oncology (Williston Park). 2001; 15: 11131119, 1123–1124; discussion 1124–1126, 1131.
  • 10
    Pienta KJ,Demers R,Hoff M,Kau TY,Montie JE,Severson RK. Effect of age and race on the survival of men with prostate cancer in Metropolitan Detroit tricounty area, 1973–1987. Urology. 1995; 45: 93101; discussion 101–102.
  • 11
    Johnson TK,Gilliland FD,Hoffman RM, et al. Racial/ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J Clin Oncol. 2004; 22: 41934201.
  • 12
    Klabunde CN,Potosky AL,Harlan LC,Kramer BS. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med Care. 1998; 36: 13371348.
  • 13
    Pettaway CA,Troncoso P,Ramirez EI,Johnston DA,Steelhammer L,Babaian RJ. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens. J Urol. 1998; 160: 437442. Comment in: J Urol. 1998; 160: 443–444.
  • 14
    McNaughton-Collins M,Walker-Corkery E,Barry MJ. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990–2000. J Natl Cancer Inst Monogr. 2004; 33: 78101.
  • 15
    Mulley AG,Barry MJ. Controversy in managing patients with prostate cancer. Banish dogma, get more data. BMJ. 1998; 316: 19191920. Comment in: BMJ. 1999; 318: 126.
  • 16
    Alibhai SM,Naglie G,Nam R,Trachtenberg J,Krahn MD. Do older men benefit from curative therapy of localized prostate cancer? J Clin Oncol. 2003; 21: 33183327.
  • 17
    Talcott JA,Clark JA. Quality of Life in prostate cancer. Eur J Cancer. 2005; 41: 922931.
  • 18
    Chan JM,Jou RM,Carroll PR. The relative impact and future burden of prostate cancer in the United States. J Urol. 2004; 172(5 pt 2): S13S16; discussion S17.
  • 19
    Litwin MS,Hays RD,Fink A,Ganz PA,Leake B,Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of health-related quality of life measure. Med Care. 1998; 36: 10021012.
  • 20
    Ware JEJr,Sherbourne CD. The MOS 36-item short-for health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30: 473483.
  • 21
    Oliver RL. Satisfaction: a behavioral perspective on the consumer. New York: McGraw-Hill; 1997.
  • 22
    Larsen DL,Attkisson CC,Hargreaves WA,Nguyen TD. Assessment of Client/patient satisfaction: development of general scale. Eval Program Plan. 1979; 2: 197207.
  • 23
    Charlson ME,Pompei P,Ales KL,MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373383.
  • 24
    Wyrwich KW,Tierney WM,Babu AN,Kroenke K,Wolinsky FD. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005; 40: 577591.
  • 25
    Norman GR,Sloan JA,Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41: 582592.
  • 26
    Robbins AS,Whittemore AS,Van Den Eeden SK. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998; 90: 986990. Comment in: J Natl Cancer Inst. 1999; 91: 801–803.
  • 27
    Polednak AP. Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998; 90: 101104.
  • 28
    Imperato PJ,Nenner RP,Will TO. Radical prostatectomy: Lower rates among African-American men. J Natl Med Assoc. 1996; 88: 589594.
  • 29
    Shavers VL,Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002; 94: 334357.
  • 30
    Denberg TD,Beaty BL,Kim FJ,Steiner JF. Marriage and ethnicity predict treatment in localized carcinoma. Cancer. 2005; 103: 18191825.
  • 31
    Knight SJ,Siston AM,Chmiel JS, et al. Ethnic variation in localized prostate cancer: a pilot study of preferences, optimism, and quality of life among black and white veterans. Clin Prostate Cancer. 2004; 3: 3137.
  • 32
    Penedo FJ,Dahn JR,Shen BJ,Schneiderman N,Antoni MH. Ethnicity and determinants of quality of life after prostate cancer treatment. Urology. 2006; 67: 10221027.
  • 33
    Campbell LC,Keefe FJ,McKee DC, et al. Prostate cancer in African Americans: relationship of patients and partner self-efficacy to quality of life. J Pain Symptom Manage. 2004; 28: 433444.
  • 34
    Hoffman RM,Hunt WC,Gilliland FD,Stephenson RA,Potosky AL. Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer. 2003; 97: 165362.